Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/899394/000119312522225815/d376301d8k.htm
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/899394/000119312522225815/d376301d8k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Harbor Biosciences, Inc..
Harbor Biosciences, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 8-K Corporate News
Ticker: HRBREvents:
CIK: 899394
Form Type: 8-K Corporate News
Accession Number: 0001193125-22-225815
Submitted to the SEC: Mon Aug 22 2022 8:23:04 AM EST
Accepted by the SEC: Mon Aug 22 2022
Period: Friday, August 19, 2022
Industry: Pharmaceutical Preparations